Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Sarcoma 9Rhabdomyosarcoma 5Wilms Tumor 2Ovarian Neoplasms 2Melanoma 2Malignant mesenchymal tumor 2Gestational Trophoblastic Disease 2Fibrosarcoma 2Testicular Neoplasms 1Teratoma, Ovarian 1Sarcoma, Alveolar Soft Part 1Rhabdoid Tumor 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Germ Cell and Embryonal 1Liposarcoma 1Kidney Neoplasms 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Desmoplastic Small Round Cell Tumor 1Dermatofibrosarcoma 1Chondrosarcoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Sunitinib 64Nivolumab 54Sorafenib 38Bevacizumab 35Axitinib 35pembrolizumab 34Everolimus 30cabozantinib 29pazopanib 26aldesleukin 26Ipilimumab 23Interleukin-2 19Specimen Handling 17Magnetic Resonance Spectroscopy 17Gemcitabine 17lenvatinib 16Interferon-alpha 15Interferon alpha-2 13Radiosurgery 12Cyclophosphamide 12fludarabine phosphate 11atezolizumab 10durvalumab 8Introns 8Erlotinib Hydrochloride 8Biopsy 8temsirolimus 7avelumab 7Radiotherapy 7Capecitabine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Renal Cell × Dactinomycin × Clear all
NCT00335556 2017-07-21

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

Children's Oncology Group

Phase 2 Completed
291 enrolled 18 charts
Genitourinary

Carcinoma, Renal Cell, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡